The MOUs that Egyptian Drug Authority signed with its counterparts in the target markets

 2023

• Zimbabwe
• South Africa
• DR Congo
• Sudan
• Yemen 

2024

• Zambia
• Cuba
• Rwanda
• Madagascar
• Nigeria

2025

• Senegal
• Brazil
• South Korea
• Angola
• The Egyptian Drug Authority achieved WHO Maturity Level 3 (ML3) for Vaccines (2022) and Medicines (2024). Following this achievement, MoUs under the Africa Continental Regulatory Reliance Framework were signed as EDA is now a (Reference Regulatory Authority). The MoUs were signed in June 2025 at Africa Health ExCon with Seven African Countries namely Zimbabwe, Rwanda, Tanzania, South Africa, Nigeria, Ghana, and Senegal.

2026

• Sierra Leone.
• Algeria
• Somalia